Information  X 
Enter a valid email address

Barkby Group PLC (BARK)

  Print   

Thursday 13 January, 2022

Barkby Group PLC

Posting of Annual Report & Notice of AGM

RNS Number : 2795Y
Barkby Group PLC
13 January 2022
 

Barkby Group PLC

("Barkby", the "Group" or the "Company")

Posting of Annual Report & Notice of AGM

Barkby Group PLC (AIM:BARK), the diversified business group, has today posted its Annual Report and Accounts for the year ended 1 July 2021 and a notice convening the Company's 2022 Annual General Meeting ("AGM"). These documents are available for viewing on the Company's website at www.barkbygroup.com.

 

Details of the AGM

 

The AGM will be held at the Company's registered office at 115b Innovation Drive, Milton, Abingdon, OX14 4RZ on 8 February 2022 at 10.00 a.m.

 

The current intention is to proceed with the holding of the AGM as an open meeting. However, it remains the board's priority to ensure the health and wellbeing of all stakeholders and given the uncertainties regarding COVID-19, it may become necessary to make alternative arrangements for the AGM and the manner in which it is held.

 

 

Enquiries: 

 

Barkby Group PLC

  via Camarco

Charles Dickson, Executive Chairman

Douglas Benzie, Chief Financial Officer




finnCap Ltd (Nomad and Broker)

+44 (0) 20 7220 0500

Carl Holmes/Simon Hicks (corporate finance)

Tim Redfern/Richard Chambers (ECM)

 




Camarco (Financial PR)

+44 (0) 20 3757 4994

Jennifer Renwick/Jake Thomas

 


 

Notes to editors

Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include; Barkby Real Estate, Barkby Pub Co. and Barkby Investments (Compromising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).

Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACSFZGMMLZKGZZM

a d v e r t i s e m e n t